DOCSLIB.ORG

ACYP1 (NM 001107) Human Untagged Clone – SC111924 | Origene

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ACYP1 (NM 001107) Human Untagged Clone – SC111924 | Origene OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for SC111924 ACYP1 (NM_001107) Human Untagged Clone Product data: Product Type: Expression Plasmids Product Name: ACYP1 (NM_001107) Human Untagged Clone Tag: Tag Free Symbol: ACYP1 Synonyms: ACYPE Vector: pCMV6-XL5 E. coli Selection: Ampicillin (100 ug/mL) Cell Selection: None Fully Sequenced ORF: >OriGene ORF within SC111924 sequence for NM_001107 edited (data generated by NextGen Sequencing) ATGGCAGAAGGAAACACCCTGATATCAGTGGATTATGAAATTTTTGGGAAGGTGCAAGGG GTGTTTTTCCGTAAGCATACTCAGGCTGAGGGTAAAAAGCTGGGATTGGTAGGCTGGGTC CAGAACACTGACCGGGGCACAGTGCAAGGACAATTGCAAGGTCCCATCTCCAAGGTGCGT CATATGCAGGAATGGCTTGAAACAAGAGGAAGTCCTAAATCACACATCGACAAAGCAAAC TTCAACAATGAAAAAGTCATCTTGAAGTTGGATTACTCAGACTTCCAAATTGTAAAATAA Clone variation with respect to NM_001107.3 5' Read Nucleotide >OriGene 5' read for NM_001107 unedited Sequence: ATTTTGTATACGACTCACTATAGGGCGGCCGCGAATTCGGCACGAGGGTTGGCGTGGTGG TCCCGGAGTGATCCTGGCAGCCGGTGGGGAAGACAGGAGGGTTTGAGCATGGCAGAAGGA AACACCCTGATATCAGTGGATTATGAAATTTTTGGGAAGGTGCAAGGGGTGTTTTTCCGT AAGCATACTCAGGCTGAGGGTAAAAAGCTGGGATTGGTAGGCTGGGTCCAGAACACTGAC CGGGGCACAGTGCAAGGACAATTGCAAGGTCCCATCTCCAAGGTGCGTCATATGCAGGAA TGGCTTGAAACAAGAGGAAGTCCTAAATCACACATCGACAAAGCAAACTTCAACAATGAA AAAGTCATCTTGAAGTTGGATTACTCAGACTTCCAAATTGTAAAATAATGGCCTGAATTT AAGTTTTCTAAGATAAACTCAGTGGTTTGGTTTTTATTATTAATAGAGATAGAACTATTG TGTGTTAATATTAGCATTAGTCAATAAGTTATTTTAATGTCAGATTTTTGAATGTTATTA TATATTACCTGTATGATGGAAGGATTACCACTGTACACAAATCTAATCAATAAAAACGTT ATAACCTTAAAAAAAAAAAAAAAAAACTCGACTCTAGATTGCGGCCGCCGGCATAGCTGT TTCCTGAACAAATCCCGGGTGGCATCCCTGTGAACCCTTCCCAGTGCCTCTCCTGCCCCT GGAAGTTGCCACTCCAGTGCCCACCACCCTTGTCCTAATAAAATTAAGTTGCATCAATTT TGCCTGACTAGGCGGCCCTTCTTTATATTATTGGGTGGAGGGGGGGGGGGATGGGAACAA GGGGCAATTTTGGGAAAACAACCTGGAGGCGCTGGGGGGTTTATTGGTGAACAA This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 ACYP1 (NM_001107) Human Untagged Clone – SC111924 3' Read Nucleotide >OriGene 3' read for NM_001107 unedited Sequence: CAATCTAGAGTCGAGTTTTTTTTTTTTTTTTTTAAGGCTTCTAACGTTTTTATTGATTAG ATTTGTGTACAGTGGTAATCCTTCCATCATACAGGTAATATATAATAACATTCAAAAATC TGACATTAAAATAACTTATTGACTAATGCTAATATTAACACACAATAGTTCTATCTCTAT TAATAATAAAAACCAAACCACTGAGTTTATCTTAGAAAACTTAAATTCAGGCCATTATTT TACAATTTGGAAGTCTGAGTAATCCAACTTCAAGATGACTTTTTCATTGTTGAAGTTTGC TTTGTCGATGTGTGATTTAAGACTTCCTCTTGTTTCAAGCCATTCCTGCATATGACGCAC CTTGGAGATGGGACCTTGCAATTGTCCTTGCACTGTGCCCCGGTCAGTGTTCTGGACCCA GCCTACCAATCCCAGCTTTTTACCCTCAGCCTGAGTATGCTTACGGAAAAACACCCCTTG CACCTTCCCAAAAATTTCATAATCCACTGATATCAGGGTGTTTCCTTCTGCCATGCTCAA ACCCTCCTTGTCTTCCCCACCGGCTGCCAGGATCACTCCGGGACCACCACGCCAACCCTC GTGCCGAATTCGCGCCGCCCTATAGTGAGTCGTATTACAAAATTCTGACGGTTCACTAAA CGAGCTCTGCTTATATAGACCTNCCACCGTACACGCCTACCGCCCATTTGCGTCAAACGG GCCGGGGTTATTACGAACATTTTGGAAAAGTCCCGTTGATTTTTGTGCCAAACAAACTCC CATTGACGTCAATGGGGTGGAGACTTGAAAATTCCCGTGAGTAAAACCGCTTTCCACGCC CTTTGTTGTACTGCCAAACCCGATTACCATGGTAAACCGCAGACAATACACTAAATGCCT GCCACATAGAAATCCCGTAAGACATGTTCTGGACTATGTCAGCGGGCCTTCACCGATTGA TTAATAGGCGGACTGTATAAGAAACTGGAGACTGCAAGGGCAGTACCCTAACTN Restriction Sites: NotI-NotI ACCN: NM_001107 Insert Size: 630 bp OTI Disclaimer: Our molecular clone sequence data has been matched to the reference identifier above as a point of reference. Note that the complete sequence of our molecular clones may differ from the sequence published for this corresponding reference, e.g., by representing an alternative RNA splicing form or single nucleotide polymorphism (SNP). RefSeq: NM_001107.3, NP_001098.1 RefSeq Size: 621 bp RefSeq ORF: 300 bp Locus ID: 97 UniProt ID: P07311 Domains: Acylphosphatase Protein Pathways: Pyruvate metabolism Gene Summary: This gene is a member of the acylphosphatase family. The encoded protein is a small cytosolic enzyme that catalyzes the hydrolysis of the carboxyl-phosphate bond of acylphosphates. Two isoenzymes have been isolated and described based on their tissue localization: erythrocyte (common) type acylphosphatase encoded by this gene, and muscle type acylphosphatase. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014] Transcript Variant: This variant (1) encodes isoform a. Both variants 1 and 3 encode the same protein. This product is to be used for laboratory only. Not for diagnostic or therapeutic use. ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 2 / 2.
Load more

Recommended publications
  • Genomic Analysis of Estrogen Cascade Reveals Histone Variant H2A.Z Associated with Breast Cancer Progression
    Molecular Systems Biology 4; Article number 188; doi:10.1038/msb.2008.25 Citation: Molecular Systems Biology 4:188 & 2008 EMBO and Nature Publishing Group All rights reserved 1744-4292/08 www.molecularsystemsbiology.com Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression Sujun Hua1,2,3,9, Caleb B Kallen4,9, Ruby Dhar1,2, Maria T Baquero5, Christopher E Mason6, Beth A Russell1,2,6, Parantu K Shah1,2, Jiang Liu1,2, Andrey Khramtsov7, Maria S Tretiakova8, Thomas N Krausz8, Olufunmilayo I Olopade7, David L Rimm5 and Kevin P White1,2,* 1 Joint Institute for Genomics and Systems Biology, The University of Chicago and Argonne National Laboratory, Chicago, IL, USA, 2 Department of Human Genetics, The University of Chicago, Chicago, IL, USA, 3 Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA, 4 Department of Gynecology and Obstetrics, Emory University, Atlanta, GA, USA, 5 Department of Pathology, Yale University, New Haven, CT, USA, 6 Department of Genetics, Yale University, New Haven, CT, USA, 7 Center for Clinical Cancer Genetics, University of Chicago Medical Center, Chicago, IL, USA and 8 Department of Pathology, The University of Chicago Hospitals, Chicago, IL, USA 9 These authors contributed equally to this work * Corresponding author. Department of Human Genetics, The University of Chicago, 1639 Pierce Drive, WMB 4211, Chicago, IL 60637, USA. Tel.: þ 1 773 834 8259; Fax: þ 1 773 834 0505; E-mail: [email protected] Received 7.9.07; accepted 13.3.08 We demonstrate an integrated approach to the study of a transcriptional regulatory cascade involved in the progression of breast cancer and we identify a protein associated with disease progression.
    [Show full text]
  • Downloaded Per Proteome Cohort Via the Web- Site Links of Table 1, Also Providing Information on the Deposited Spectral Datasets
    www.nature.com/scientificreports OPEN Assessment of a complete and classifed platelet proteome from genome‑wide transcripts of human platelets and megakaryocytes covering platelet functions Jingnan Huang1,2*, Frauke Swieringa1,2,9, Fiorella A. Solari2,9, Isabella Provenzale1, Luigi Grassi3, Ilaria De Simone1, Constance C. F. M. J. Baaten1,4, Rachel Cavill5, Albert Sickmann2,6,7,9, Mattia Frontini3,8,9 & Johan W. M. Heemskerk1,9* Novel platelet and megakaryocyte transcriptome analysis allows prediction of the full or theoretical proteome of a representative human platelet. Here, we integrated the established platelet proteomes from six cohorts of healthy subjects, encompassing 5.2 k proteins, with two novel genome‑wide transcriptomes (57.8 k mRNAs). For 14.8 k protein‑coding transcripts, we assigned the proteins to 21 UniProt‑based classes, based on their preferential intracellular localization and presumed function. This classifed transcriptome‑proteome profle of platelets revealed: (i) Absence of 37.2 k genome‑ wide transcripts. (ii) High quantitative similarity of platelet and megakaryocyte transcriptomes (R = 0.75) for 14.8 k protein‑coding genes, but not for 3.8 k RNA genes or 1.9 k pseudogenes (R = 0.43–0.54), suggesting redistribution of mRNAs upon platelet shedding from megakaryocytes. (iii) Copy numbers of 3.5 k proteins that were restricted in size by the corresponding transcript levels (iv) Near complete coverage of identifed proteins in the relevant transcriptome (log2fpkm > 0.20) except for plasma‑derived secretory proteins, pointing to adhesion and uptake of such proteins. (v) Underrepresentation in the identifed proteome of nuclear‑related, membrane and signaling proteins, as well proteins with low‑level transcripts.
    [Show full text]
  • Characterisation of Genetic Regulatory Effects for Osteoporosis Risk Variants in Human Osteoclasts Benjamin H
    Mullin et al. Genome Biology (2020) 21:80 https://doi.org/10.1186/s13059-020-01997-2 RESEARCH Open Access Characterisation of genetic regulatory effects for osteoporosis risk variants in human osteoclasts Benjamin H. Mullin1,2*, Jennifer Tickner2, Kun Zhu1,2, Jacob Kenny2, Shelby Mullin1,2, Suzanne J. Brown1, Frank Dudbridge3, Nathan J. Pavlos2, Edward S. Mocarski4, John P. Walsh1,5†, Jiake Xu2† and Scott G. Wilson1,2,6† Abstract Background: Osteoporosis is a complex disease with a strong genetic contribution. A recently published genome- wide association study (GWAS) for estimated bone mineral density (eBMD) identified 1103 independent genome- wide significant association signals. Most of these variants are non-coding, suggesting that regulatory effects may drive many of the associations. To identify genes with a role in osteoporosis, we integrate the eBMD GWAS association results with those from our previous osteoclast expression quantitative trait locus (eQTL) dataset. Results: We identify sixty-nine significant cis-eQTL effects for eBMD GWAS variants after correction for multiple testing. We detect co-localisation of eBMD GWAS and osteoclast eQTL association signals for 21 of the 69 loci, implicating a number of genes including CCR5, ZBTB38, CPE, GNA12, RIPK3, IQGAP1 and FLCN. Summary-data-based Mendelian Randomisation analysis of the eBMD GWAS and osteoclast eQTL datasets identifies significant associations for 53 genes, with TULP4 presenting as a strong candidate for pleiotropic effects on eBMD and gene expression in osteoclasts. By performing analysis using the GARFIELD software, we demonstrate significant enrichment of osteoporosis risk variants among high-confidence osteoclast eQTL across multiple GWAS P value thresholds.
    [Show full text]
  • Autocrine IFN Signaling Inducing Profibrotic Fibroblast Responses By
    Downloaded from http://www.jimmunol.org/ by guest on September 23, 2021 Inducing is online at: average * The Journal of Immunology , 11 of which you can access for free at: 2013; 191:2956-2966; Prepublished online 16 from submission to initial decision 4 weeks from acceptance to publication August 2013; doi: 10.4049/jimmunol.1300376 http://www.jimmunol.org/content/191/6/2956 A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Autocrine IFN Signaling Feng Fang, Kohtaro Ooka, Xiaoyong Sun, Ruchi Shah, Swati Bhattacharyya, Jun Wei and John Varga J Immunol cites 49 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130037 6.DC1 This article http://www.jimmunol.org/content/191/6/2956.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 23, 2021. The Journal of Immunology A Synthetic TLR3 Ligand Mitigates Profibrotic Fibroblast Responses by Inducing Autocrine IFN Signaling Feng Fang,* Kohtaro Ooka,* Xiaoyong Sun,† Ruchi Shah,* Swati Bhattacharyya,* Jun Wei,* and John Varga* Activation of TLR3 by exogenous microbial ligands or endogenous injury-associated ligands leads to production of type I IFN.
    [Show full text]
  • Integrated Bioinformatics Analysis Reveals Novel Key Biomarkers and Potential Candidate Small Molecule Drugs in Gestational Diabetes Mellitus
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.09.434569; this version posted March 10, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gestational diabetes mellitus Basavaraj Vastrad1, Chanabasayya Vastrad*2, Anandkumar Tengli3 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karnataka, India. 3. Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysuru and JSS Academy of Higher Education & Research, Mysuru, Karnataka, 570015, India * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2021.03.09.434569; this version posted March 10, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Gestational diabetes mellitus (GDM) is one of the metabolic diseases during pregnancy. The identification of the central molecular mechanisms liable for the disease pathogenesis might lead to the advancement of new therapeutic options. The current investigation aimed to identify central differentially expressed genes (DEGs) in GDM. The transcription profiling by array data (E-MTAB-6418) was obtained from the ArrayExpress database. The DEGs between GDM samples and non GDM samples were analyzed with limma package. Gene ontology (GO) and REACTOME enrichment analysis were performed using ToppGene. Then we constructed the protein-protein interaction (PPI) network of DEGs by the Search Tool for the Retrieval of Interacting Genes database (STRING) and module analysis was performed.
    [Show full text]
  • Supplementary Material Peptide-Conjugated Oligonucleotides Evoke Long-Lasting Myotonic Dystrophy Correction in Patient-Derived C
    Supplementary material Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice Arnaud F. Klein1†, Miguel A. Varela2,3,4†, Ludovic Arandel1, Ashling Holland2,3,4, Naira Naouar1, Andrey Arzumanov2,5, David Seoane2,3,4, Lucile Revillod1, Guillaume Bassez1, Arnaud Ferry1,6, Dominic Jauvin7, Genevieve Gourdon1, Jack Puymirat7, Michael J. Gait5, Denis Furling1#* & Matthew J. A. Wood2,3,4#* 1Sorbonne Université, Inserm, Association Institut de Myologie, Centre de Recherche en Myologie, CRM, F-75013 Paris, France 2Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, UK 3Department of Paediatrics, John Radcliffe Hospital, University of Oxford, Oxford, UK 4MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, UK 5Medical Research Council, Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, UK 6Sorbonne Paris Cité, Université Paris Descartes, F-75005 Paris, France 7Unit of Human Genetics, Hôpital de l'Enfant-Jésus, CHU Research Center, QC, Canada † These authors contributed equally to the work # These authors shared co-last authorship Methods Synthesis of Peptide-PMO Conjugates. Pip6a Ac-(RXRRBRRXRYQFLIRXRBRXRB)-CO OH was synthesized and conjugated to PMO as described previously (1). The PMO sequence targeting CUG expanded repeats (5′-CAGCAGCAGCAGCAGCAGCAG-3′) and PMO control reverse (5′-GACGACGACGACGACGACGAC-3′) were purchased from Gene Tools LLC. Animal model and ASO injections. Experiments were carried out in the “Centre d’études fonctionnelles” (Faculté de Médecine Sorbonne University) according to French legislation and Ethics committee approval (#1760-2015091512001083v6). HSA-LR mice are gift from Pr. Thornton. The intravenous injections were performed by single or multiple administrations via the tail vein in mice of 5 to 8 weeks of age.
    [Show full text]
  • A Systems Analysis of the Chemosensitivity of Breast Cancer
    BMC Medicine BioMed Central Research article Open Access A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047 Wen-Lin Kuo*1, Debopriya Das1, Safiyyah Ziyad1, Sanchita Bhattacharya1, William J Gibb1, Laura M Heiser1, Anguraj Sadanandam1, Gerald V Fontenay1, Zhi Hu2, Nicholas J Wang1, Nora Bayani1, Heidi S Feiler1, Richard M Neve1, Andrew J Wyrobek1, Paul T Spellman1, Laurence J Marton3 and Joe W Gray1,2 Address: 1Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA, 2Comprehensive Cancer Center, University of California, San Francisco, California, USA and 3Progen Pharmaceuticals, Redwood City, California, USA Email: Wen-Lin Kuo* - [email protected]; Debopriya Das - [email protected]; Safiyyah Ziyad - [email protected]; Sanchita Bhattacharya - [email protected]; William J Gibb - [email protected]; Laura M Heiser - [email protected]; Anguraj Sadanandam - [email protected]; Gerald V Fontenay - [email protected]; Zhi Hu - [email protected]; Nicholas J Wang - [email protected]; Nora Bayani - [email protected]; Heidi S Feiler - [email protected]; Richard M Neve - [email protected]; Andrew J Wyrobek - [email protected]; Paul T Spellman - [email protected]; Laurence J Marton - [email protected]; Joe W Gray - [email protected] * Corresponding author Published: 14 December 2009 Received: 17 November 2009 Accepted: 14 December 2009 BMC Medicine 2009, 7:77 doi:10.1186/1741-7015-7-77 This article is available from: http://www.biomedcentral.com/1741-7015/7/77 © 2009 Kuo et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
    [Show full text]
  • Proteomic Landscape of the Human Choroid–Retinal Pigment Epithelial Complex
    Supplementary Online Content Skeie JM, Mahajan VB. Proteomic landscape of the human choroid–retinal pigment epithelial complex. JAMA Ophthalmol. Published online July 24, 2014. doi:10.1001/jamaophthalmol.2014.2065. eFigure 1. Choroid–retinal pigment epithelial (RPE) proteomic analysis pipeline. eFigure 2. Gene ontology (GO) distributions and pathway analysis of human choroid– retinal pigment epithelial (RPE) protein show tissue similarity. eMethods. Tissue collection, mass spectrometry, and analysis. eTable 1. Complete table of proteins identified in the human choroid‐RPE using LC‐ MS/MS. eTable 2. Top 50 signaling pathways in the human choroid‐RPE using MetaCore. eTable 3. Top 50 differentially expressed signaling pathways in the human choroid‐RPE using MetaCore. eTable 4. Differentially expressed proteins in the fovea, macula, and periphery of the human choroid‐RPE. eTable 5. Differentially expressed transcription proteins were identified in foveal, macular, and peripheral choroid‐RPE (p<0.05). eTable 6. Complement proteins identified in the human choroid‐RPE. eTable 7. Proteins associated with age related macular degeneration (AMD). This supplementary material has been provided by the authors to give readers additional information about their work. © 2014 American Medical Association. All rights reserved. 1 Downloaded From: https://jamanetwork.com/ on 09/25/2021 eFigure 1. Choroid–retinal pigment epithelial (RPE) proteomic analysis pipeline. A. The human choroid‐RPE was dissected into fovea, macula, and periphery samples. B. Fractions of proteins were isolated and digested. C. The peptide fragments were analyzed using multi‐dimensional LC‐MS/MS. D. X!Hunter, X!!Tandem, and OMSSA were used for peptide fragment identification. E. Proteins were further analyzed using bioinformatics.
    [Show full text]
  • Extensive Cargo Identification Reveals Distinct Biological Roles of the 12 Importin Pathways Makoto Kimura1,*, Yuriko Morinaka1
    1 Extensive cargo identification reveals distinct biological roles of the 12 importin pathways 2 3 Makoto Kimura1,*, Yuriko Morinaka1, Kenichiro Imai2,3, Shingo Kose1, Paul Horton2,3, and Naoko 4 Imamoto1,* 5 6 1Cellular Dynamics Laboratory, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan 7 2Artificial Intelligence Research Center, and 3Biotechnology Research Institute for Drug Discovery, 8 National Institute of Advanced Industrial Science and Technology (AIST), AIST Tokyo Waterfront 9 BIO-IT Research Building, 2-4-7 Aomi, Koto-ku, Tokyo, 135-0064, Japan 10 11 *For correspondence: [email protected] (M.K.); [email protected] (N.I.) 12 13 Editorial correspondence: Naoko Imamoto 14 1 15 Abstract 16 Vast numbers of proteins are transported into and out of the nuclei by approximately 20 species of 17 importin-β family nucleocytoplasmic transport receptors. However, the significance of the multiple 18 parallel transport pathways that the receptors constitute is poorly understood because only limited 19 numbers of cargo proteins have been reported. Here, we identified cargo proteins specific to the 12 20 species of human import receptors with a high-throughput method that employs stable isotope 21 labeling with amino acids in cell culture, an in vitro reconstituted transport system, and quantitative 22 mass spectrometry. The identified cargoes illuminated the manner of cargo allocation to the 23 receptors. The redundancies of the receptors vary widely depending on the cargo protein. Cargoes 24 of the same receptor are functionally related to one another, and the predominant protein groups in 25 the cargo cohorts differ among the receptors. Thus, the receptors are linked to distinct biological 26 processes by the nature of their cargoes.
    [Show full text]
  • Systematic Surveys of Iron Homeostasis Mechanisms Reveal Ferritin Superfamily and Nucleotide Surveillance Regulation to Be Modif
    cells Article Systematic Surveys of Iron Homeostasis Mechanisms Reveal Ferritin Superfamily and Nucleotide Surveillance Regulation to be Modified by PINK1 Absence Jana Key 1,2, Nesli Ece Sen 1,2, Aleksandar Arsovi´c 1, Stella Krämer 1, Robert Hülse 1, Natasha Nadeem Khan 1, David Meierhofer 3 , Suzana Gispert 1, Gabriele Koepf 1 and Georg Auburger 1,* 1 Experimental Neurology, Medical School, Goethe University, 60590 Frankfurt am Main, Germany; [email protected] (J.K.); [email protected] (N.E.S.); [email protected] (A.A.); [email protected] (S.K.); [email protected] (R.H.); [email protected] (N.N.K.); [email protected] (S.G.); [email protected] (G.K.) 2 Faculty of Biosciences, Goethe-University, Altenhöferallee 1, 60438 Frankfurt am Main, Germany 3 Max Planck Institute for Molecular Genetics, Ihnestraße 63-73, 14195 Berlin, Germany; [email protected] * Correspondence: [email protected]; Tel.: +49-(0)-69-6301-7428 Received: 3 September 2020; Accepted: 29 September 2020; Published: 2 October 2020 Abstract: Iron deprivation activates mitophagy and extends lifespan in nematodes. In patients suffering from Parkinson’s disease (PD), PINK1-PRKN mutations via deficient mitophagy trigger iron accumulation and reduce lifespan. To evaluate molecular effects of iron chelator drugs as a potential PD therapy, we assessed fibroblasts by global proteome profiles and targeted transcript analyses. In mouse cells, iron shortage decreased protein abundance for iron-binding nucleotide metabolism enzymes (prominently XDH and ferritin homolog RRM2). It also decreased the expression of factors with a role for nucleotide surveillance, which associate with iron-sulfur-clusters (ISC), and are important for growth and survival.
    [Show full text]
  • Systematic Surveys of Iron Homeostasis Mechanisms Reveal Ferritin Superfamily and Nucleotide Surveillance Regulation to Be Modif
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 5 September 2020 doi:10.20944/preprints202009.0108.v1 1 Article 2 Systematic Surveys of Iron Homeostasis Mechanisms 3 reveal Ferritin Superfamily and Nucleotide Surveillance 4 Regulation to be modified by PINK1 Absence 5 Jana Key 1,2, Nesli Ece Sen 1,2, Aleksandar Arsovic 1, Stella Krämer 1, Robert Hülse 1, Natasha 6 Nadeem Khan 1, David Meierhofer 3, Suzana Gispert 1, Gabriele Koepf 1, and Georg Auburger 1,* 7 1 Experimental Neurology, Goethe University Medical School, 60590 Frankfurt am Main, Germany 8 2 Faculty of Biosciences, Goethe-University, Altenhöferallee 1, 60438 Frankfurt am Main, Germany 9 3 Max Planck Institute for Molecular Genetics, Ihnestraße 63-73, 14195 Berlin, Germany 10 * Correspondence: [email protected] 11 12 Abstract: Iron deprivation activates mitophagy and extends lifespan in nematodes. In patients 13 suffering from Parkinson’s disease (PD), PINK1-PRKN mutations via deficient mitophagy trigger 14 iron accumulation and reduce lifespan. To evaluate molecular effects of iron chelator drugs as a 15 potential PD therapy, we assessed fibroblasts by global proteome profiles and targeted transcript 16 analyses. In mouse cells, iron shortage decreased protein abundance for iron-binding nucleotide 17 metabolism enzymes (prominently XDH and ferritin homolog RRM2). It also decreased the 18 expression of factors with a role for nucleotide surveillance, which associate with iron-sulfur- 19 clusters (ISC), and are important for growth and survival. This widespread effect included 20 prominently Nthl1-Ppat-Bdh2, but also mitochondrial Glrx5-Nfu1-Bola1, cytosolic Aco1-Abce1-Tyw5, 21 and nuclear Dna2-Elp3-Pold1-Prim2.
    [Show full text]
  • A Systems Analysis of the Chemosensitivity of Breast Cancer Cells to the Polyamine Analogue PG-11047
    A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047 Wen-Lin Kuo1*, Debopriya Das1, Safiyyah Ziyad1, Sanchita Bhattacharya1, William J Gibb1, Laura M Heiser1, Anguraj Sadanandam1, Gerald V Fontenay1, Zhi Hu2, Nicholas J Wang1, Nora Bayani1, Heidi S Feiler1, Richard M Neve1, Andrew J Wyrobek1, Paul T Spellman1, Laurence J. Marton3 and Joe W Gray1,2 1Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, USA 2Comprehensive Cancer Center, University of California, San Francisco, California, USA 3Progen Pharmaceuticals, Redwood City, California, USA *Corresponding author Email addresses: WK: [email protected] DD: [email protected] SZ: [email protected] SB: [email protected] WJG: [email protected] LMH: [email protected] AS: [email protected] GVF: [email protected] ZH: [email protected] NJW: [email protected] NB: [email protected] HSF: [email protected] RMN: [email protected] AJW: [email protected] PTS: [email protected] LJM: [email protected] JWG: [email protected] Abstract Background Polyamines regulate important cellular functions and polyamine dysregulation frequently occurs in cancer. The objective of this study was to use a systems approach to study the relative effects of PG-11047, a polyamine analogue, across breast cancer cells derived from different patients and to identify genetic markers associated with differential cytotoxicity. Methods A panel of 48 breast cell lines that mirror many transcriptional and genomic features present in primary human breast tumours were used to study the antiproliferative activity of PG- 11047. Sensitive cell lines were further examined for cell cycle distribution and apoptotic response.
    [Show full text]